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Abstract 
AIM: To examine the efficacy and safety of Narrowband ultraviolet B (NB-UVB) in Vietnamese vitiligo patients. 
METHODS: We recruited thirty-one patients (14 males, 17 females), aged from 7 to 67 years, with both 
segmental vitiligo (SV) and non-segmental vitiligo (NSV), treated three times weekly with NB-UVB. The starting 
dose for adults from 15 years old and children less than 15 years old was 200 mJ/cm
2
 and 150 mJ/cm
2
, 
respectively, with 50 mJ/cm
2
 and 20 mJ/cm
2
 dose increments at each subsequent visit, respectively, until mild 
erythema lasting less than 24 hrs reported by patient, given for a period of 6 months. Response to therapy was 
assessed based on VASI score changes.  
RESULTS: Based upon our results, 38.7% (12/31) of patients achieved a very good response of more than 50% 
VASI changes, 41.9% (13/31) obtained a good response (VASI changed from 25 to 50%). Total good and very 
good response to therapy significantly increased with prolonged treatment, increasing from 19.4% to 64.5% and 
80.6% after 2, 4 and 6 months, respectively. Localised NSV patients obtained good and very good response 
significantly more frequently than generalised NSV (55.6% versus 18.2%). Adverse effects were minimal, of which 
one case developed herpes simplex, and 4 cases reported mild photo burn reaction which completely 
disappeared after adjusting the dose.  
CONCLUSION: NB-UVB therapy is an effective and safe tool in the management of Vietnamese vitiligo patients. 
 
 
 
 
 
 
Introduction 
 
Vitiligo is a common, chronic, acquired 
cutaneous de-pigmentation disorder with serious 
emotional and psychological consequences [1], [2]. 
There are many possible conventional or 
unconventional therapeutic choice for the treatment 
[3], [4]. Narrow-band ultraviolet B (NB-UVB) is one of 
the best treatment modality for vitiligo because of its 
safety, effectiveness and non-evasive nature, 
promoting stabilisation of the depigmenting process 
and stimulation of residual follicular melanocytes [5].  
The present study aims to examine the 
efficacy and safety of NB-UVB therapy in Vietnamese 
vitiligo patients, attending the Vietnam National 
Hospital of Dermatology and Venereology from 
October 2016 to September 2017. 
 
 
Methods 
 
 A total of 31 vitiligo patients (14 males, 17 
females; 28 with Fitzpatrick skin’s type IV and only 3 
patients with Fitzpatrick skin’s type III), mean age 30 
years old. The majority of patients (29/31) had NSV, 
and only 2 patients had SV. 
Local NB-UVB 311 nm irradiation was 
indicated for vitiligo patients with 2% and less than 2% 
body surface involved (12 patients). Whole body NB-
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UVB 311 nm irradiation was indicated for those with 
more than 2% body surface involved (19 patients). 
Patients were treated with thrice-weekly exposures on 
non-consecutive days. The starting dose for adults 
from 15 years old and children less than 15 years old 
was 200 mJ/cm
2
 and 150 mJ/cm
2
, respectively, with 
50 mJ/cm
2
 and 20 mJ/cm
2
 dose increments at each 
subsequent visit, respectively, until mild erythema 
lasting less than 24 hrs reported by patient, given for a 
period of 6 months. The response to NB-UVB therapy 
was examined based on changes of vitiligo area 
severity index (VASI) after treatment, which took into 
account of both percentage of re-pigmentation and the 
reduction of lesion’s area [6]. 
 
 
Results 
 
After 6-month treatment, 38.7% obtained a 
very good response, 41.9% patients achieved a good 
response, the proportion of poor, very poor and no 
response was equally and accounted for only 6.5% as 
shown in Figure 1.  
 
Figure 1: A case of 10 years old male with very good response to 
therapy: (a) before treatment, (b) after 2 months -VASI decreased 
16.4%, (c) after 4 months - VASI decreased 58%, (c) after 6 months 
VASI decreased 95% 
 
Association between response to therapy and 
the duration of the treatment was shown in Figure 2. 
 
Figure 2: Association between response to therapy and the duration 
of the treatment 
Among 31 patients, total good and very good 
response to therapy were significantly associated with 
prolonged treatment, increasing from 19.4% to 64.5% 
and 80.6% after 2, 4 and 6-month treatment, 
respectively. Association between response to 
therapy and localised or generalised NSV was shown 
in Figure 3.  
 
Figure 3: Association between response to therapy and localised or 
generalised NSV 
 
Total good and very good response to therapy 
was observed in localised NSV significantly more 
frequently than in generalised NSV patients (55.6% 
versus 18.2%). This difference is statistically different. 
In our study, good and very good response to 
therapy significantly increased with prolonged 
treatment and was observed in localised NSV 
significantly more frequently than in generalised NSV 
patients, which are consistent with previous studies 
[7], [8], [9], [10]. The actual good and very good 
response rate to therapy will properly be higher if the 
evaluation time is longer than 6 months. Adverse 
effects in our study were minimal which is similar to 
that reported in the literature. 
In conclusion, our study proves that NB-UVB 
therapy is an effective and safe tool in the 
management of Vietnamese vitiligo patients. Further 
study is recommended to prolong the treatment 
duration and follow up the stability of re-pigmentation. 
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